A 48-year-old man is admitted to the hospital with a new diagnosis of HIV and Toxoplasma encephalitis. Treatment is immediately started with pyrimethamine, sulfadiazine, and leucovorin. Repeat brain imaging 2 weeks later demonstrates substantial improvement. He started on antiretroviral therapy, completed 6 weeks of acute therapy for Toxoplasma encephalitis, and then transitioned to chronic maintenance therapy (secondary prophylaxis). At a visit 18 months after the initial diagnosis of toxoplasmosis, the HIV RNA is undetectable (and has been undetectable for 15 months), the CD4 count has increased from a baseline of 34 cells/mm3 to 189 cells/mm3, and all neurologic symptoms have resolved.
For this man who has successfully completed initial (acute) therapy for Toxoplasma encephalitis and has complete resolution of neurologic symptoms, when can they stop chronic maintenance therapy for Toxoplasma encephalitis (assume he will continue to take antiretroviral therapy with virologic suppression)?
Sign In or Register Progress Not Saved!
Since you are not signed in, your progress won't be saved.
Since you are not signed in, your progress won't be saved.
Question Last Updated
February 1st, 2025
February 1st, 2025
Steps to Acquire CE for this Question Bank Topic:
1
Answer
Answer all questions
2
Score 80%+
Answer correctly
3
Claim CE
Choose CNE or CME
4
Give Feedback
Complete survey
5
Bictegravir-Tenofovir alafenamide-Emtricitabine Biktarvy
Darunavir-Cobicistat-Tenofovir alafenamide-Emtricitabine Symtuza
Dolutegravir-Abacavir-Lamivudine Triumeq
Dolutegravir-Lamivudine Dovato
Dolutegravir-Rilpivirine Juluca
Doravirine-Tenofovir DF-Lamivudine Delstrigo
Efavirenz-Tenofovir DF-Emtricitabine Atripla
Elvitegravir-Cobicistat-Tenofovir alafenamide-Emtricitabine Genvoya
Elvitegravir-Cobicistat-Tenofovir DF-Emtricitabine Stribild
Rilpivirine-Tenofovir alafenamide-Emtricitabine Odefsey
Rilpivirine-Tenofovir DF-Emtricitabine Complera
Fostemsavir Rukobia
Ibalizumab Trogarzo
Maraviroc Selzentry
Dolutegravir Tivicay
Raltegravir Isentress
Tenofovir alafenamide-Emtricitabine Descovy
Tenofovir DF-Emtricitabine Truvada and Multiple Generics
Doravirine Pifeltro
Efavirenz Sustiva
Etravirine Intelence
Rilpivirine Edurant